PDS Biotech Announces Expansion of its VERSATILE-002 Clinical Trial into Europe

Go back to PDS Biotech Announces Expansion of its VERSATILE-002 Clinical Trial into Europe
(NASDAQ: PDSB) Delayed: 0.75 +0.02 (2.74%)
Previous Close $0.73    52 Week High
Open $0.75    52 Week Low
Day High $0.76    P/E N/A 
Day Low $0.73    EPS
Volume 408,248